Cargando…

Clinical evaluation of zaleplon in the treatment of insomnia

Zaleplon is a pyrazolopyrimidine hypnotic used for the treatment of insomnia. Zaleplon binds preferentially at the α1β2γ2 subunit of gamma aminobutyric acid type A (GABA(A)) receptors in the central nervous system, and has a half-life of about one hour. Efficacy studies show that zaleplon is a suita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebbens, Marieke M, Verster, Joris C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630939/ https://www.ncbi.nlm.nih.gov/pubmed/23616704

Ejemplares similares

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity
por: Haggag, Yusuf A., et al.
Publicado: (2021)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Inclusion and Exclusion Criteria of Clinical Trials for Insomnia
por: Huls, Hendrikje, et al.
Publicado: (2018)

Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation
por: Ali, Sarah A., et al.
Publicado: (2022)

A Visual ERP Study of Impulse Inhibition following a Zaleplon-Induced Nap after Sleep Deprivation
por: Zhang, Qianru, et al.
Publicado: (2014)

Investigation of the usefulness of zaleplon at two doses to induce afternoon-sleep under noise interference and its effects on psychomotor performance and vestibular function
por: Chen, Liang-En, et al.
Publicado: (2016)

Insomnia Complaints and Perceived Immune Fitness in Young Adults with and without Self-Reported Impaired Wound Healing
por: Balikji, Jessica, et al.
Publicado: (2022)

The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome Complaints
por: Balikji, Stephanie, et al.
Publicado: (2018)

The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA(A) Receptors Containing γ1, γ2, and γ3 Subunits
por: Richter, Grant, et al.
Publicado: (2020)

Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients
por: Khalifa, Maha K. A., et al.
Publicado: (2019)

Insomnia: Its Causes and Treatment
Publicado: (1913)

Clinical management of behavioral insomnia of childhood
por: Vriend, Jennifer, et al.
Publicado: (2011)

Korean Clinical Practice Guideline for the Diagnosis and Treatment of Insomnia in Adults
por: Choi, Hayun, et al.
Publicado: (2020)

Is exercise an alternative treatment for chronic insomnia?
por: Passos, Giselle Soares, et al.
Publicado: (2012)

Energy drinks mixed with alcohol: misconceptions, myths, and facts
por: Verster, Joris C, et al.
Publicado: (2012)

Diagnosis and treatment of chronic insomnia
por: Saddichha, Sahoo
Publicado: (2010)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Tackling sleeplessness: Psychological treatment options for insomnia
por: Dautovich, Natalie D, et al.
Publicado: (2010)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

The Treatment of Insomnia
Publicado: (1881)

The Assessment of Immune Fitness
por: Verster, Joris C., et al.
Publicado: (2022)

Suggestions for the Treatment of Insomnia
por: Cunnington, C. Willett
Publicado: (1911)

The Physical Treatment of Insomnia
por: Whitby, C. J.
Publicado: (1900)

Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia
por: Stummer, Lauren, et al.
Publicado: (2018)

Insomnia in Adolescence
por: Donskoy, Innessa, et al.
Publicado: (2018)

Melatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?
por: Rolling, Julie, et al.
Publicado: (2022)

Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review
por: Wallace, Douglas M., et al.
Publicado: (2020)

Indiplon in the management of insomnia
por: Lemon, Michael D, et al.
Publicado: (2009)

Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
por: Mogavero, Maria P, et al.
Publicado: (2023)

Tackling sleeplessness: psychological treatment options for insomnia in older adults
por: Dzierzewski, Joseph M, et al.
Publicado: (2010)

The Treatment of Insomnia of Pulmonary Tuberculosis
por: Reisman, S. C.
Publicado: (1902)

The Treatment of Insomnia by Drugs
Publicado: (1902)

The Drug Treatment of Insomnia
Publicado: (1898)

A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
por: Mattos, Meghan K, et al.
Publicado: (2021)

The societal costs of insomnia
por: Wade, Alan G
Publicado: (2011)

Genetic Pathways to Insomnia
por: Lind, Mackenzie J., et al.
Publicado: (2016)

Insomnia and Nerve Strain
Publicado: (1909)

Advances in the management of insomnia
por: Pigeon, Wilfred R., et al.
Publicado: (2014)

Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal
por: Pelayo, Rafael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v6ita0jomji8190mj7eh2dt8p1